CRISPR-Cas9: A Cutting-edge Genome-editing Technology with Many Potential Applications
Journal of Advances in Biology & Biotechnology · pp. 59–73 · Published 30 Oct 2024
10.9734/jabb/2024/v27i111591Abstract
Unregulated human activities are responsible for climate change which is a major factor for the emergence of new infectious (bacterial, viral, fungus, and parasitic) and non-infectious diseases (genetic disorders, cancers, etc.). To tackle this situation, we must have better therapeutics, diagnostics, and vaccines for the treatment and prevention of emerging diseases in humans and animals. To address the aforementioned issues, CRISPR-Cas9, a revolutionary genome editing tool, can help us develop better therapeutics, diagnostics, and vaccines in a short time. In addition, it can be used to achieve food security by improving productivity, adaptability, and resilience traits in plants and animals. In nature, most bacteria and archaea have CRISPR as a part of their adaptive immune system that helps bacteria defend themselves from phages, viruses, and other foreign genetic elements. CRISPR-Cas9 is a highly effective, simple, and accurate genome editing tool compared to previous genome editing tools such as meganucleases, Zinc finger nucleases (ZFNs), and transcription activators like effector nucleases (TALENs). This review article discusses the different components and working of the CRISPR-Cas9 system, and how CRISPR-Cas9 plays a significant role in the development of next-generation therapeutics, diagnostics, vaccine platforms, and improved crops and livestock species for food security.
Cited by 1
1 citation reported by external sources — individual citing-article records aren't available to list yet.
Related research
- Knowledge, Acceptance and Perception on COVID-19 Vaccine among Sudanese People in Khartoum State, 2020-2021 — shares topic coverage
- Aerosols in Dental Practice- A Neglected Infectious Vector — shares topic coverage
- Descriptive Analysis of Ebola virus Proteins: Towards Development of Effective Therapeutics and Vaccines — shares topic coverage
- Reports on COVID-19 Vaccines and Vaccination in Nigeria — shares topic coverage
- The New Pandemic Covid-19: Treatment Options and Developments — shares topic coverage
Article metrics
Real usage data collected on this platform.
17
Page views
0
PDF downloads
5
Outbound clicks
1
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.